🇺🇸 FDA

Drug profile · INN

theophylline

NUELIN

FDA: approved TGA: approved
US status
approved
Patents linked
2
News articles
0

Quick answer

theophylline (NUELIN) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN theophylline
Brand NUELIN
Route INJECTION
Formulation TABLET, EXTENDED RELEASE
Originator Lacuna Pharma Pty Ltd

Related patents

Search patents →

  1. US 9107912

    Methods for concomitant treatment of theophylline and febuxostat

    Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8372872

    Methods for concomitant treatment of theophylline and febuxostat

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is theophylline?

theophylline (NUELIN) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for theophylline?

NUELIN is a marketed brand name for theophylline. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of theophylline?

theophylline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.